Piper Sandler Cuts Vicarious Surgical (NYSE:RBOT) Price Target to $8.50

Vicarious Surgical (NYSE:RBOT) had its price objective decreased by Piper Sandler from $10.50 to $8.50 in a research note released on Tuesday morning,Benzinga reports. Piper Sandler currently has a neutral rating on the stock.

Vicarious Surgical Price Performance

NYSE:RBOT opened at $7.98 on Tuesday. The firm has a 50-day moving average of $12.30 and a two-hundred day moving average of $10.56. The stock has a market cap of $47.15 million, a P/E ratio of -0.78 and a beta of 1.35. Vicarious Surgical has a 1-year low of $4.27 and a 1-year high of $19.00.

Vicarious Surgical (NYSE:RBOT) last issued its quarterly earnings results on Monday, March 17th. The company reported ($2.43) EPS for the quarter, beating analysts’ consensus estimates of ($2.69) by $0.26. The business had revenue of $2.09 million during the quarter. During the same period in the prior year, the company earned ($2.25) earnings per share. As a group, equities analysts expect that Vicarious Surgical will post -10.89 earnings per share for the current year.

Institutional Trading of Vicarious Surgical

A number of hedge funds and other institutional investors have recently made changes to their positions in RBOT. Renaissance Technologies LLC raised its stake in Vicarious Surgical by 11.6% during the fourth quarter. Renaissance Technologies LLC now owns 11,534 shares of the company’s stock valued at $152,000 after buying an additional 1,200 shares in the last quarter. Geode Capital Management LLC increased its holdings in shares of Vicarious Surgical by 8.2% in the 4th quarter. Geode Capital Management LLC now owns 30,799 shares of the company’s stock valued at $405,000 after acquiring an additional 2,336 shares during the last quarter. Finally, DnB Asset Management AS raised its position in shares of Vicarious Surgical by 21.1% during the 4th quarter. DnB Asset Management AS now owns 21,213 shares of the company’s stock valued at $279,000 after acquiring an additional 3,692 shares in the last quarter. Institutional investors own 47.27% of the company’s stock.

About Vicarious Surgical

Vicarious Surgical Inc operates as a robotics technology company in the United States. The company focuses on developing and commercializing Vicarious System, a single-incision surgical robot that virtually transports surgeons inside the patient to perform minimally invasive surgery. Vicarious Surgical Inc was incorporated in 2014 and is headquartered in Waltham, Massachusetts.